10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001641172-25-011033`
Period End Date	20250331
Filing Date	20250515
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 118 Income Statement 60 Cash Flow Statement 122 Stockholders Equity 40

Balance Sheet 118 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$898.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$898.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$1.35M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$1.35M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$2.28M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$2.28M	USD	Point-in-time
Other Receivables	`OtherReceivablesNetCurrent`	$19.00K	USD	Point-in-time
Other Receivables	`OtherReceivablesNetCurrent`	$19.00K	USD	Point-in-time
Other Receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Other Receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$318.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$318.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.58M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.53M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.53M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$98.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$98.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$108.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$108.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	72.29M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	72.29M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	72.29M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	72.29M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$618.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$618.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.53M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$554.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$554.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.27M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.27M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.59M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.59M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$745.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$745.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.11M	USD	Point-in-time
Total assets	`Assets`	$8.61M	USD	Point-in-time
Total assets	`Assets`	$8.61M	USD	Point-in-time
Total assets	`Assets`	$6.25M	USD	Point-in-time
Total assets	`Assets`	$6.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.38M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$639.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$639.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$606.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$606.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$234.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$234.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$239.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$239.00K	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$1.95M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$1.95M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.31M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.54M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$395.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$395.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$338.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$338.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$9.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.11M	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 72,290,030 and 65,526,320 as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$72.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 72,290,030 and 65,526,320 as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$72.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 72,290,030 and 65,526,320 as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 72,290,030 and 65,526,320 as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$425.44M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$425.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-426.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-426.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-430.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-430.53M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$4.83M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$4.83M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$6.00M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$6.00M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$6.25M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$6.25M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$8.61M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$8.61M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.00K	USD	1 Quarter
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.00K	USD	1 Quarter
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$16.00K	USD	1 Quarter
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$16.00K	USD	1 Quarter
Total Revenues	`Revenues`	$40.00K	USD	1 Quarter
Total Revenues	`Revenues`	$40.00K	USD	1 Quarter
Total Revenues	`Revenues`	$16.00K	USD	1 Quarter
Total Revenues	`Revenues`	$16.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$10.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$10.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$8.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$8.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.08M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.08M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.95M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.95M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.81M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.81M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.54M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.54M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$3.63M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$3.63M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$5.77M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$5.77M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.73M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.73M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.62M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.62M	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$27.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$27.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-92.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-92.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$81.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$81.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$11.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$11.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	$124.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	$124.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	$72.00K	USD	1 Quarter
Interest Expense and Other Finance Costs	`InterestExpense`	$72.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.12	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.05	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-0.05	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.12	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.05	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-0.05	USD	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	70.33M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	70.33M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	49.46M	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	49.46M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	70.33M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	70.33M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	49.46M	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	49.46M	shares	1 Quarter

Cash Flow Statement 122 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$9.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$9.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$10.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$10.00K	USD	1 Quarter
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$335.00K	USD	1 Quarter
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$335.00K	USD	1 Quarter
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	-	USD	1 Quarter
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	-	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$49.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$49.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$48.00K	USD	1 Quarter
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$48.00K	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfDebtDiscountPremium`	$64.00K	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfDebtDiscountPremium`	$64.00K	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfDebtDiscountPremium`	$73.00K	USD	1 Quarter
Amortization of Debt Discount and Other Expenses	`AmortizationOfDebtDiscountPremium`	$73.00K	USD	1 Quarter
Non-cash lease expense	`OtherNoncashIncomeExpense`	$67.00K	USD	1 Quarter
Non-cash lease expense	`OtherNoncashIncomeExpense`	$67.00K	USD	1 Quarter
Non-cash lease expense	`OtherNoncashIncomeExpense`	$-64.00K	USD	1 Quarter
Non-cash lease expense	`OtherNoncashIncomeExpense`	$-64.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$60.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$60.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$27.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$27.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-92.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-92.00K	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$19.00K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$19.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-367.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-367.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$62.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$62.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$119.00K	USD	1 Quarter
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$119.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-62.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-62.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$60.00K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$60.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$124.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$124.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$561.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$561.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-540.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-540.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$62.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$62.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.82M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.82M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.36M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.36M	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.04M	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.04M	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.00K	USD	1 Quarter
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$158.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$158.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$91.00K	USD	1 Quarter
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$91.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$50.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$50.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$56.00K	USD	1 Quarter
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$56.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-158.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-158.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$898.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$898.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$329.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$329.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$1.26M	USD	Point-in-time
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$1.26M	USD	Point-in-time
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$660.00K	USD	1 Quarter
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$660.00K	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.50M	USD	1 Quarter
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.50M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.83M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.83M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$660.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$660.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.14M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.14M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-803.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-803.00K	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$898.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$898.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$898.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$898.00K	USD	Point-in-time
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$96.00K	USD	1 Quarter
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$96.00K	USD	1 Quarter
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$-73.00K	USD	1 Quarter
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$-73.00K	USD	1 Quarter
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	$421.00K	USD	1 Quarter
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	$421.00K	USD	1 Quarter
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	-	USD	1 Quarter
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	-	USD	1 Quarter

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.00M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.00M	USD	Point-in-time
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$329.00K	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$329.00K	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$660.00K	USD	1 Quarter
Common Stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$660.00K	USD	1 Quarter
Common Stock issuance, net of costs, shares	`StockIssuedDuringPeriodSharesNewIssues`	2.05M	shares	1 Quarter
Common Stock issuance, net of costs, shares	`StockIssuedDuringPeriodSharesNewIssues`	2.05M	shares	1 Quarter
Equity based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$60.00K	USD	1 Quarter
Equity based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$60.00K	USD	1 Quarter
Repayment of Debt with shares	`StockIssuedDuringPeriodValueOther`	$450.00K	USD	1 Quarter
Repayment of Debt with shares	`StockIssuedDuringPeriodValueOther`	$450.00K	USD	1 Quarter
Net comprehensive loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net comprehensive loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net comprehensive loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net comprehensive loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Cashless Exercise of Warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfWarrants`	-	USD	1 Quarter
Cashless Exercise of Warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfWarrants`	-	USD	1 Quarter
Committed Shares	`StockIssuedDuringPeriodValueCommittedShares`	-	USD	1 Quarter
Committed Shares	`StockIssuedDuringPeriodValueCommittedShares`	-	USD	1 Quarter
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.00M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.